AEHR files Form 144 to sell common shares
AEHR submitted a Form 144 disclosing proposed sales of Common stock and recent restricted‑stock vesting events.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AEHR submitted a Form 144 disclosing proposed sales of Common stock and recent restricted‑stock vesting events. The filing lists restricted stock vesting of 558 shares on 01/27/2025 and 1,158 shares on 04/11/2025. It also reports a sale of 4,546 shares on 01/22/2026 for $142,750.68. The filing references NASDAQ and includes a filing date of 04/16/2026.
Insights
Routine resale notice with restricted‑stock vesting and a recent open‑market disposition.
The Form 144 lists scheduled restricted stock vesting events totaling 1,716 shares (558 and 1,158) and documents a prior sale of 4,546 shares for $142,750.68. These items are typical disclosure of planned or recent insider sales under Rule 144 reporting requirements.
Cash‑flow treatment and the identity of the selling beneficial owner are shown in the filing lines; timing and methods of future resale are not detailed beyond the listed dates.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Vesting financial
Securities Sold During The Past 3 Months regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does AEHR's Form 144 report?
Does the filing state where AEHR is listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.